News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Company News

Advanced Search
Show 5102550100 per page
More Company News
06/10/2021

Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted...

06/09/2021

By Victor Crawford, Chief Executive Officer, Pharmaceutical Segment

06/03/2021

By Tiffany Olson, president of Nuclear & Precision Health Solutions at Cardinal Health. From HealthCare Business News magazine: Precision medicine is an area of healthcare that targets treatment...

06/03/2021

Four years after the approval of the first CAR-T cell therapies, oncologists are referring more patients for treatment and becoming more comfortable with the cost. However, payer approvals and...

View all company news »

* Required Fields